Antibody response to influenza vaccination in the elderly: A quantitative review

Vaccine

Volumn 24, Issue 8, 2006, Pages 1159-1169

  Goodwin, Katherine ^a   Viboud, Cécile ^b   Simonsen, Lone ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Aging immunology; Antibodies; Influenza vaccine; Review

Indexed keywords

INACTIVATED VACCINE; INFLUENZA VACCINE;

ACTIVE IMMUNIZATION; ADOLESCENT; ADULT; AGED; ANTIBODY RESPONSE; CIRCULATION; CONTROLLED STUDY; DRUG EFFICACY; DRUG FORMULATION; HUMAN; IMMUNOGENICITY; INFECTION PREVENTION; INFECTION RISK; INFLUENZA; INFLUENZA VACCINATION; MAJOR CLINICAL STUDY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PRIORITY JOURNAL; PROBABILITY; QUANTITATIVE ANALYSIS; REVIEW; SEROCONVERSION;

EID: 32044453088     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2005.08.105     Document Type: Article

References (54)

1. W.W. Thompson, D.K. Shay, E. Weintraub, L. Brammer, N. Cox, and L.J. Anderson Mortality associated with influenza and respiratory syncytial virus in the United States JAMA 289 2003 179 186
2. L. Simonsen, T.A. Reichert, C. Viboud, W.C. Blackwelder, R.J. Taylor, and M.A. Miller Impact of influenza vaccination on seasonal mortality in the US elderly population Arch Intern Med 165 3 2005 265 272
3. Centers for Disease Control and Prevention. Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 2004;53(RR-06)1-40 (available: http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5306a1.htm ).
4. T. Vu, S. Farish, M. Jenkins, and H. Kelly A meta-analysis of effectiveness of influenza vaccine in persons aged 65 years and over living in the community Vaccine 20 2002 1831 1836
5. D.M. Murasko, E.D. Bernstein, E.M. Gardner, P. Gross, G. Munk, and S. Dran Role of humoral and cell-mediated immunity in protection from influenza disease after immunization of healthy elderly Exp Gerontol 37 2-3 2002 427 439
6. J.J. Goronzy, J.W. Fulbright, C.S. Crowson, G.A. Poland, W.M. O'Fallon, and C.M. Weyand Value of immunological markers in predicting responsiveness to influenza vaccination in elderly individuals J Virol 75 2001 12182 12187
7. W.E. Beyer, A.M. Palache, M. Baljet, and N. Masurel Antibody induction by influenza vaccines in the elderly: a review of the literature Vaccine 7 5 1989 385 394 [Review]
8. D. Hobson, R.L. Curry, A.S. Beare, and A. Ward-Gardner The role of serum haemagglutination-inhibiting antibody in protection against challenge infection with influenza A2 and B viruses J Hyg (Lond) 70 4 1972 767 777
9. C.W. Potter, and J.S. Oxford Determinants of immunity to influenza infection in man Br Med Bull 35 1 1979 69 75 [Review]
10. P.A. Gross, C. Russo, S. Dran, P. Cataruozolo, G. Munk, and S.C. Lancey Time to earliest peak serum antibody response to influenza vaccine in the elderly Clin Diagn Lab Immunol 4 4 1997 491 492
11. S. Rastogi, P.A. Gross, J. Bonelli, S. Dran, R.A. Levandowski, and C. Russo Time to peak serum antibody response to influenza vaccine Clin Diagn Lab Immunol 2 1 1995 120 121
12. A.M. Palache, W.E. Beyer, M.J. Sprenger, N. Masurel, S. de Jonge, and A. Vardy Antibody response after influenza immunization with various vaccine doses: a double-blind, placebo-controlled, multi-centre, dose-response study in elderly nursing-home residents and young volunteers Vaccine 11 1 1993 3 9
13. G.J. Ligthart, J.X. Corberand, C. Fournier, P. Galanaud, W. Hijmans, and B. Kennes Admission criteria for immunogerontological studies in man: the SENIEUR protocol Mech Ageing Dev 28 1 1984 47 55
14. WHO report on global surveillance and response. 2000 WHO/CDS/CSR/ISR/ 2000.1 available: http://www.who.int/emc-documents/surveillance/docs/ whocdscsrisr2001.html/Tableofcontents/about.htm#Copyright.
15. P.A. Gross, G.V. Quinnan Jr., M.E. Weksler, U. Setia, and R.G. Douglas Jr. Relation of chronic disease and immune response to influenza vaccine in the elderly Vaccine 7 4 1989 303 308
16. T. Zei, M. Neri, and A.M. Iorio Immunogenicity of trivalent subunit and split influenza vaccines (1989-90 winter season) in volunteers of different groups of age Vaccine 9 9 1991 613 617
17. M. Chernesky, D. O'neill, L. Pickard, S. Castriciano, D. Kraftcheck, and J. Sellors Immunogenicity and adverse reactions of influenza vaccination in elderly patients given acetaminophen or placebo Clin Diagn Virol 1 2 1993 129 136
18. I.A. de Bruijn, E.J. Remarque, W.E. Beyer, S. le Cessie, N. Masurel, and G.J. Lightart Annually repeated influenza vaccination improves humoral responses to several influenza virus strains in healthy elderly Vaccine 15 12-13 1997 1323 1329
19. J.E. McElhaney, G.S. Meneilly, K.E. Lechelt, B.L. Beattie, and R.C. Bleackley Antibody response to whole-virus and split-virus influenza vaccines in successful ageing Vaccine 11 10 1993 1055 1060
20. E.J. Remarque, I.A. de Bruijn, W.J. Boersma, N. Masurel, and G.J. Ligthart Altered antibody response to influenza H1N1 vaccine in healthy elderly people as determined by HI, ELISA, and neutralization assay J Med Virol 55 1 1998 82 87
21. H. Glathe, S. Bigl, and A. Grosche Comparison of humoral immune responses to trivalent influenza split vaccine in young, middle-aged and elderly people Vaccine 11 7 1993 702 705
22. P.A. Gross, R.A. Levandowski, C. Russo, M. Weksler, J. Bonelli, and S. Dran Vaccine immune response and side effects with the use of acetaminophen with influenza vaccine Clin Diagn Lab Immunol 1 2 1994 134 138
23. B. Lina, M.A. Fletcher, M. Valette, P. Saliou, and M. Aymard A TritonX-100-split virion influenza vaccine is safe and fulfills the committee for proprietary medicinal products (CPMP) recommendations for the European Community for Immunogenicity, in Children, Adults and the Elderly Biologicals 28 2 2000 95 103
24. D.C. Powers, and R.B. Belshe Effect of age on cytotoxic T lymphocyte memory as well as serum and local antibody responses elicited by inactivated influenza virus vaccine J Infect Dis 167 3 1993 584 592
25. M. Minutello, F. Senatore, G. Cecchinelli, M. Bianchi, T. Andreani, and A. Podda Safety and immunogenicity of an inactivated subunit influenza virus vaccine combined with MF59 adjuvant emulsion in elderly subjects, immunized for three consecutive influenza seasons Vaccine 17 2 1999 99 104
26. E. Bernstein, D. Kaye, E. Abrutyn, P. Gross, M. Dorfman, and D.M. Murasko Immune response to influenza vaccination in a large healthy elderly population Vaccine 17 1 1999 82 94
27. S. De Donato, D. Granoff, M. Minutello, G. Lecchi, M. Faccini, and M. Agnello Safety and immunogenicity of MF59-adjuvanted influenza vaccine in the elderly Vaccine 17 23-24 1999 3094 3101
28. E.M. Gardner, E.D. Bernstein, S. Dran, G. Munk, P. Gross, and E. Abrutyn Characterization of antibody responses to annual influenza vaccination over four years in a healthy elderly population Vaccine 19 32 2001 4610 4617
29. E.M. Gardner, E.D. Bernstein, K.A. Popoff, E. Abrutyn, P. Gross, and D.M. Murasko Immune response to influenza vaccine in healthy elderly: lack of association with plasma beta-carotene, retinol, alpha-tocopherol, or zinc Mech Ageing Dev 117 1-3 2000 29 45
30. C. Van Hoecke, V. Prikazsky, I. Uto, and C. Menschikowski Immunogenicity of an inactivated split influenza vaccine in institutionalized elderly patients Gerontology 42 4 1996 190 198
31. A.M. Iorio, A. Alatri, B. Camilloni, M. Neri, G. Baglio, and I. Donatelli Antibody response to 1995-1996 influenza vaccine in institutionalized and non-institutionalized elderly women Gerontology 45 1 1999 31 38
32. C. Buxton Bridges, K. Fukuda, R.C. Holman, A.M. De Guzman, R.A. Hodder, and I.H. Gomolin Decreased antibody response among nursing home residents who received recalled influenza vaccine and results of revaccination Vaccine 18 11-12 2000 1103 1109
33. M. Muszkat, G. Friedman, H.D. Dannenberg, E. Greenbaum, M. Lipo, and Y. Heymann Response to influenza vaccination in community and in nursing home residing elderly: relation to clinical factors Exp Gerontol 38 10 2003 1199 1203
34. V. Baldo, T. Menegon, C. Bonello, A. Floreani, R. Trivello Collaborative Group Comparison of three different influenza vaccines in institutionalised elderly Vaccine 19 25-26 2001 3472 3475
35. M. Muszkat, E. Greenbaum, A. Ben-Yehuda, M. Oster, E. Yeu'l, and S. Heimann Local and systemic immune response in nursing-home elderly following intranasal or intramuscular immunization with inactivated influenza vaccine Vaccine 21 11-12 2003 1180 1186
36. F. Pregliasco, C. Mensi, W. Serpilli, L. Speccher, P. Masella, and A. Belloni Immunogenicity and safety of three commercial influenza vaccines in institutionalized elderly Aging (Milano) 13 1 2001 38 43
37. S. Squarcione, S. Sgricia, L.R. Biasio, and E. Perinetti Comparison of the reactogenicity and immunogenicity of a split and a subunit-adjuvanted influenza vaccine in elderly subjects Vaccine 21 11-12 2003 1268 1274
38. L. Stepanova, A. Naykhin, C. Kolmskog, G. Jonson, I. Barantceva, and M. Bichurina The humoral response to live and inactivated influenza vaccines administered alone and in combination to young adults and elderly J Clin Virol 24 3 2002 193 201
39. L.B. Brydak, M. Machala, J. Mysliwska, A. Mysliwski, and P. Trzonkowski Immune response to influenza vaccination in an elderly population J Clin Immunol 23 3 2003 214 222
40. R.B. Belshe, F.K. Newman, J. Cannon, C. Duane, J. Treanor, and J. Treanor Serum antibody responses after intradermal vaccination against influenza N Engl J Med 351 22 2004 2286 2294
41. S.A. Frech, R.T. Kenney, C.A. Spyr, H. Lazar, J.F. Viret, and C. Herzog Improved immune responses to influenza vaccination in the elderly using an immunostimulant patch Vaccine 23 7 2005 946 950
42. M. Hara, K. Tanaka, and Y. Hirota Immune response to influenza vaccine in healthy adults and the elderly: association with nutritional status Vaccine 23 12 2005 1457 1463
43. B.R. Ruf, K. Colberg, M. Frick, and A. Preusche Open randomized study to compare the immunogenicity and reactogenicity of an influenza split vaccine with an MF59-adjuvanted subunit vaccine and a virosome-based subunit vaccine in elderly Infection 32 4 2004 191 198
44. G. Wick, and B. Grubeck-Loebenstein Primary and secondary alterations of immune reactivity in the elderly: impact of dietary factors and disease Immunol Rev 160 1997 171 184 [Review]
45. M.E. Weksler, and P. Szabo The effect of age on the B-cell repertoire J Clin Immunol 20 4 2000 240 249 [Review]
46. Govaert TME, Thijs CTMCN, N. Masurel, Sprenger MJW, G.J. Dinant, and J.A. Knottnerus The efficacy of influenza vaccination in elderly individuals JAMA 272 1994 1661 1665
47. P. Mangtani, P. Cumberland, C.R. Hodgson, J.A. Roberts, F.T. Cutts, and A.J. Hall A cohort study of the effectiveness of influenza vaccine in older people, performed using the United Kingdom general practice research database J Infect Dis 190 1 2004 1 10
48. Demicheli V, Rivetti D, Deeks JJ, Jefferson TO. Vaccines for preventing influenza in healthy adults. The Cochrane Database of Systematic Reviews 2004;(3). doi: 10.1002/14651858.CD001269.pub2. [Art. No.: CD001269.pub2.].
49. P.A. Gross, M.E. Weksler, G.V. Quinnan Jr., R.G. Douglas Jr., P.F. Gaerlan, and C.R. Denning Immunization of elderly people with two doses of influenza vaccine J Clin Microbiol 25 9 1987 1763 1765
50. H.A. Cromwell, F.B. Brandon, I.W. McLean Jr., and JF. Sadusk Jr. Influenza immunization. A new vaccine JAMA 210 8 1969 1438 1442
51. C. Hannoun, M. Barme, C. Serie, H. Beck, J. Aquino, and M. Thibon Antibody response to anti-A/New Jersey/76 vaccines Dev Biol Stand 39 1977 249 252
52. Y. Deng, Y. Jing, A.E. Campbell, and S. Gravenstein Age-related impaired type 1 T cell responses to influenza: reduced activation ex vivo, decreased expansion in CTL culture in vitro, and blunted response to influenza vaccination in vivo in the elderly J Immunol 172 6 2004 3437 3446
53. I. Kang, M.S. Hong, H. Nolasco, S.H. Park, J.M. Dan, and J.Y. Choi Age-associated change in the frequency of memory CD4+ T cells impairs long term CD4+ T cell responses to influenza vaccine J Immunol 173 2004 673 681
54. M. Saurwein-Teissl, T.L. Lung, F. Marx, C. Gschosser, E. Asch, and I. Blasko Lack of antibody production following immunization in old age: association with CD8(+)CD28(-) T cell clonal expansions and an imbalance in the production of Th1 and Th2 cytokines J Immunol 168 11 2002 5893 5899